Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | THRB | P10828 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | PLG | P00747 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 3/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 1/20 | 0.42 |
| ▸ | GABRD | O14764 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexane SCHEMBL3760865 | 0.94 | LMNA (0.50) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL14322259 | 0.88 | LMNA (0.56) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL7250811 | 0.88 | LMNA (0.56) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL27467045 | 0.88 | LMNA (0.56) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL1442288 | 0.88 | LMNA (0.56) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL2030994 | 0.88 | LMNA (0.56) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL4758861 | 0.88 | LMNA (0.56) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL7438483 | 0.88 | LMNA (0.56) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL20767099 | 0.88 | LMNA (0.56) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL28064250 | 0.88 | LMNA (0.56) | LMNATHRBKMT2AMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230372267-A1 | AFFINITY MEDICANT CONJUGATE | Califia Pharma Inc. (US) | 2023-11-23 | — | — | US | disclosed |
| CN-116762002-A | Sensor for unbiased proteome studies, methods of making and using the same | 纳米马赛克公司 | 2023-09-15 | — | — | CN | disclosed |
| US-11576876-B2 | Affinity Medicant Conjugate | AF CHEMICALS, LLC (US) | 2023-02-14 | — | — | US | disclosed |
| US-20220133649-A1 | AFFINITY MEDICANT CONJUGATE | Califia Pharma Inc. (US) | 2022-05-05 | — | — | US | disclosed |
| US-11241398-B2 | Affinity medicant conjugate | AF CHEMICALS, LLC (US) | 2022-02-08 | — | — | US | disclosed |
| US-11135182-B2 | Affinity medicant conjugates | AF CHEMICALS, LLC (US) | 2021-10-05 | — | — | US | disclosed |
| US-20210299063-A1 | AFFINITY MEDICANT CONJUGATE | AF CHEMICALS, LLC (US) | 2021-09-30 | — | — | US | disclosed |
| US-20210077425-A1 | AFFINITY MEDICANT CONJUGATE | AF CHEMICALS, LLC (US) | 2021-03-18 | — | — | US | disclosed |
| WO-2013056096-A1 | POLYPEPTIDE-OPIOID CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2013-04-18 | — | — | WO | disclosed |
| EP-2445523-A2 | COMPOSITIONS AND METHODS FOR PREPARING STAPHYLOCOCCUS AUREUS SEROTYPE 5 AND 8 CAPSULAR POLYSACCHARIDE CONJUGATE IMMUNOGENIC COMPOSITIONS | Wyeth LLC (US) | 2012-05-02 | — | — | EP | disclosed |
| US-20110223645-A1 | Multivalent Carriers of Bi-Specific Antibodies | IMMUNOMEDICS, INC. (US) | 2011-09-15 | — | — | US | disclosed |
| WO-2011041003-A9 | COMPOSITIONS AND METHODS FOR PREPARING STAPHYLOCOCCUS AUREUS SEROTYPE 5 AND 8 CAPSULAR POLYSACCHARIDE CONJUGATE IMMUNOGENIC COMPOSITIONS | WYETH LLC (US) | 2011-06-09 | — | — | WO | disclosed |
| US-7951921-B2 | Multivalent carriers of bi-specific antibodies | IMMUNOMEDICS, INC. (US) | 2011-05-31 | — | — | US | disclosed |
| WO-2011041003-A2 | COMPOSITIONS AND METHODS FOR PREPARING STAPHYLOCOCCUS AUREUS SEROTYPE 5 AND 8 CAPSULAR POLYSACCHARIDE CONJUGATE IMMUNOGENIC COMPOSITIONS | WYETH LLC (US) | 2011-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210299063-A1 | AFFINITY MEDICANT CONJUGATE | FCER2, HDGF, FCGR2A | LMNA 3666/4885THRB 3480/4885KMT2A 573/4885 |
| US-20230372267-A1 | AFFINITY MEDICANT CONJUGATE | FCER2, HDGF, FCGR2A | LMNA 3666/4885THRB 3480/4885KMT2A 573/4885 |
| US-20220133649-A1 | AFFINITY MEDICANT CONJUGATE | FCER2, HDGF, FCGR2A | LMNA 3666/4885THRB 3480/4885KMT2A 573/4885 |
| US-20110223645-A1 | Multivalent Carriers of Bi-Specific Antibodies | FCGR3B, FCGR2A, FCGR1A | LMNA 4347/4885THRB 2068/4885KMT2A 2873/4885 |
| US-11576876-B2 | Affinity Medicant Conjugate | FCER2, HDGF, FCGR2A | LMNA 3666/4885THRB 3480/4885KMT2A 573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.